Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07107152 · ClinicalTrials.gov registry record · NA
Effect of Static vs. Conversational AI-Generated Messages on Colorectal Cancer Screening Intent: a Randomized Controlled Trial
A NA study, sponsored by University of Pennsylvania.
- Completed
- Registry status
- NA
- Development phase
- 915
- Enrollment target
NCT07107152: Completed NA study, sponsored by University of Pennsylvania.
NCT07107152 is a NA study that has completed, run by University of Pennsylvania. The registered enrollment target is 915 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07107152, a NA study, has completed, sponsored by University of Pennsylvania.
- COMPLETED
- Registry status
- NA
- Development phase
- 915 participants
- Enrollment target
Study Summary
The goal of this clinical trial is to assess whether messages generated by a large language model (LLM), including both static and conversational formats, can increase colorectal cancer (CRC) screening intentions among U.S. adults aged 45-75 who have never completed CRC screening. The main questions it aims to answer are: Do personalized, AI-generated messages increase the self-reported likelihood of completing a stool-based CRC screening test within 12 months? Do they also increase intent to undergo colonoscopy screening within 12 months? Researchers will compare four groups: (1) no message control, (2) expert-written patient education materials, (3) a single AI-generated persuasive message, and (4) a motivational interviewing-style AI chatbot. These comparisons will help assess whether a conversational format offers added benefit over static AI or expert-generated content. Participants will: Be randomly assigned to one of the four study arms Spend at least 3 minutes reading or interacting with their assigned material Complete pre- and post-intervention surveys assessing intent to receive CRC screening Receive messages tailored to their self-reported demographics, including age, political ideology, gender, education, community setting (urban, rural, suburb), self-reported health, and the last time they saw their PCP
Interventions
- BEHAVIORAL single GPT generated message
- BEHAVIORAL AI Chatbot
- BEHAVIORAL Expert-Written Patient Materials
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 915 participants |
| Start Date | 2025-06-11 |
| Est. Completion | 2025-06-21 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07107152
The ClinicalTrials.gov registry entry for NCT07107152 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 915 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pennsylvania, which has 1,423 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which single GPT generated message is the first listed.
NCT07107152 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07107152 about?
NCT07107152 is a clinical study titled "Effect of Static vs. Conversational AI-Generated Messages on Colorectal Cancer Screening Intent: a Randomized Controlled Trial". The goal of this clinical trial is to assess whether messages generated by a large language model (LLM), including both static and conversational formats, can increase colorectal cancer (CRC) screening intentions among U.S. adults aged 45-75 who have never completed CRC screening. The main questions...
What is the current status of trial NCT07107152?
This trial is currently completed. It is a NA study. The enrollment target is 915 participants. The study started on 2025-06-11. Estimated completion is 2025-06-21.
What interventions are being tested in trial NCT07107152?
The interventions under investigation include: single GPT generated message (BEHAVIORAL), AI Chatbot (BEHAVIORAL), Expert-Written Patient Materials (BEHAVIORAL).
Who is sponsoring clinical trial NCT07107152?
This trial is sponsored by University of Pennsylvania, which has 1,423 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.